 |
(6aR, 10aR)-3-(1′,1′-dimethylheptyl)-delta-8-tetrahydro-cannabinol-9-carboxylic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Systemic scleroderma |
| EU Market Approval | EU |
| EU Designation Date | 2017-01-12 00:00:00 |
| Sponsor | TMC Pharma Services Ltd |
| |
(6aR, 10aR)-3-(1′,1′-dimethylheptyl)-delta-8-tetrahydro-cannabinol-9-carboxylic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Systemic scleroderma |
| EU Market Approval | EU |
| EU Designation Date | 2017-01-12 00:00:00 |
| Sponsor | TMC Pharma Services Ltd |